We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-12.93%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$102B
AUM Growth
-$16.3B
Cap. Flow
+$749M
Cap. Flow %
0.73%
Top 10 Hldgs %
23.72%
Holding
4,322
New
210
Increased
1,790
Reduced
1,850
Closed
304
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FATE icon
2651
Fate Therapeutics
FATE
$294M
$739K ﹤0.01%
29,815
+379
+1% +$10.5K
CPE
2652
DELISTED
Callon Petroleum Company
CPE
$739K ﹤0.01%
18,854
+1,583
+9% +$84.7K
STC icon
2653
Stewart Information Services
STC
$2B
$738K ﹤0.01%
14,838
+1,612
+12% +$86.5K
FFBW
2654
DELISTED
FFBW, Inc. Common Stock
FFBW
$737K ﹤0.01%
60,697
+300
+0.5% +$3.6K
FIBK icon
2655
First Interstate BancSystem
FIBK
$3.7B
$735K ﹤0.01%
19,293
+9,653
+100% +$344K
IBDW icon
2656
iShares iBonds Dec 2031 Term Corporate ETF
IBDW
$2.55B
$732K ﹤0.01%
35,198
+5,948
+20% +$127K
SCHE icon
2657
Schwab Emerging Markets Equity ETF
SCHE
$12.9B
$732K ﹤0.01%
28,854
+16,646
+136% +$435K
KBWY icon
2658
Invesco KBW Premium Yield Equity REIT ETF
KBWY
$311M
$731K ﹤0.01%
33,093
+17,835
+117% +$414K
PGHY icon
2659
Invesco Global ex-US High Yield Corporate Bond ETF
PGHY
$227M
$730K ﹤0.01%
37,871
-36,340
-49% -$716K
ABMD
2660
DELISTED
Abiomed Inc
ABMD
$730K ﹤0.01%
2,951
+1,328
+82% +$358K
QQQ icon
2661
CALL
Invesco QQQ Trust
QQQ
$487B
$729K ﹤0.01%
42,500
GDL
2662
GDL Fund
GDL
$91.7M
$728K ﹤0.01%
88,674
-520,980
-85% -$4.33M
QCRH icon
2663
QCR Holdings
QCRH
$1.73B
$728K ﹤0.01%
13,475
+800
+6% +$43.6K
SABA
2664
Saba Capital Income & Opportunities Fund II
SABA
$222M
$728K ﹤0.01%
82,493
-4,633
-5% -$42.9K
CHW
2665
Calamos Global Dynamic Income Fund
CHW
$553M
$725K ﹤0.01%
106,341
-16,979
-14% -$130K
NMFC icon
2666
New Mountain Finance
NMFC
$736M
$725K ﹤0.01%
60,884
-6,189
-9% -$79.7K
NKX icon
2667
Nuveen California AMT-Free Quality Municipal Income Fund
NKX
$666M
$724K ﹤0.01%
56,237
+2,926
+5% +$38.2K
OEFA
2668
ALPS O'Shares International Developed Quality Dividend ETF
OEFA
$37.6M
$723K ﹤0.01%
31,985
-1,731
-5% -$41.6K
SPMB icon
2669
State Street SPDR Portfolio Mortgage Backed Bond ETF
SPMB
$7.07B
$721K ﹤0.01%
31,572
-3,487
-10% -$80.3K
ROOF
2670
DELISTED
NYLI CBRE NextGen Real Estate ETF
ROOF
$721K ﹤0.01%
34,159
+114
+0.3% +$2.69K
EMBC icon
2671
Embecta
EMBC
$290M
$720K ﹤0.01%
+28,447
New +$820K
FSLR icon
2672
First Solar
FSLR
$24B
$719K ﹤0.01%
10,547
-16,249
-61% -$1.16M
CEM
2673
DELISTED
ClearBridge MLP and Midstream Fund Inc.
CEM
$719K ﹤0.01%
25,037
-2,091
-8% -$70.2K
G icon
2674
Genpact
G
$5.78B
$716K ﹤0.01%
16,900
-4,135
-20% -$175K
RWK icon
2675
Invesco S&P MidCap 400 Revenue ETF
RWK
$1.35B
$715K ﹤0.01%
9,132
+312
+4% +$26.9K

Similar funds

Raymond James & Associates's Q2 2022 Portfolio in Review

As of Q2 2022, Raymond James & Associates held 4,322 positions worth $102B, down 14% from $119B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q2 2022 filing shows 210 new, 1,790 increased, 1,850 reduced and 304 closed positions. Its largest new stake was Aspen Technology Inc: 54,037 shares worth $9.93M. The largest sale was iShares Core MSCI EAFE ETF, an estimated $551M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q2 2022 buy was Aspen Technology Inc: 54,037 shares worth $9.93M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2022, an estimated $471M increase.
  • Raymond James & Associates's biggest Q2 2022 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $551M.
  • Raymond James & Associates fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $21.5M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $102B portfolio in Q2 2022.
  • Raymond James & Associates opened 210 new positions and closed 304 in Q2 2022.
  • Raymond James & Associates's portfolio value fell 14% quarter-over-quarter to $102B.

Based on Raymond James & Associates's 13F filing for Q2 2022, filed 12 Aug 2022.